📊 BDMDW Key Takeaways
Is Baird Medical Investment Holdings Ltd (BDMDW) a Good Investment?
Baird Medical Investment Holdings Ltd presents an uninvestable profile due to complete absence of financial data in SEC EDGAR filings. The company shows virtually no operational metrics, no revenue reporting, and no accounting data across income statement, balance sheet, or cash flow statements. Without fundamental financial information, no meaningful analysis of profitability, growth quality, or financial health is possible.
Baird Medical shows strong underlying profitability, with 2024 revenue up about 18% year over year, gross margin above 88%, and operating income growing faster than sales. However, growth quality is weakened by poor cash conversion, negative operating cash flow, and a large buildup in receivables and prepayments, which makes the otherwise strong earnings profile less durable until working capital normalizes.
Why Buy Baird Medical Investment Holdings Ltd Stock? BDMDW Key Strengths
- No strengths identified
- High-margin business model with 2024 gross profit of about $32.7 million on $37.0 million of revenue
- Profitable growth, with operating income rising to about $15.3 million and net income to about $12.6 million in 2024
- Equity base remains positive and current assets exceed current liabilities, supporting near-term balance sheet flexibility
BDMDW Stock Risks: Baird Medical Investment Holdings Ltd Investment Risks
- No revenue or profitability data available
- No balance sheet information or asset base disclosed
- No cash flow metrics to assess operational viability
- Likely pre-revenue or shell company status
- Complete absence of financial transparency
- No insider activity or management conviction signals
- Operating cash flow was negative in 2024 despite solid net income, indicating weak earnings-to-cash conversion
- Accounts receivable rose to about $46.6 million, materially above annual revenue run-rate, increasing collection and credit-risk exposure
- Customer concentration increased, with four customers representing more than 10% each of 2024 revenue, while liabilities and bank borrowings also climbed sharply
Key Metrics to Watch
- Revenue and gross profit once operations commence
- Operating cash flow generation capability
- Capital structure and debt levels
- Accounts receivable growth and days sales outstanding versus revenue growth
- Operating cash flow and free cash flow recovery relative to reported net income
Baird Medical Investment Holdings Ltd (BDMDW) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
BDMDW Profit Margin, ROE & Profitability Analysis
BDMDW vs Healthcare Sector: How Baird Medical Investment Holdings Ltd Compares
How Baird Medical Investment Holdings Ltd compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Baird Medical Investment Holdings Ltd Stock Overvalued? BDMDW Valuation Analysis 2026
Based on fundamental analysis, Baird Medical Investment Holdings Ltd has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Baird Medical Investment Holdings Ltd Balance Sheet: BDMDW Debt, Cash & Liquidity
BDMDW Revenue Growth, EPS Growth & YoY Performance
BDMDW SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Baird Medical Investment Holdings Ltd (CIK: 0001982444)
❓ Frequently Asked Questions about BDMDW
What is the AI rating for BDMDW?
Baird Medical Investment Holdings Ltd (BDMDW) has a Combined AI Rating of SELL from Claude (STRONG SELL) and ChatGPT (HOLD) with 84% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are BDMDW's key strengths?
Claude: . ChatGPT: High-margin business model with 2024 gross profit of about $32.7 million on $37.0 million of revenue. Profitable growth, with operating income rising to about $15.3 million and net income to about $12.6 million in 2024.
What are the risks of investing in BDMDW?
Claude: No revenue or profitability data available. No balance sheet information or asset base disclosed. ChatGPT: Operating cash flow was negative in 2024 despite solid net income, indicating weak earnings-to-cash conversion. Accounts receivable rose to about $46.6 million, materially above annual revenue run-rate, increasing collection and credit-risk exposure.
What is BDMDW's revenue and growth?
Baird Medical Investment Holdings Ltd reported revenue of N/A.
Does BDMDW pay dividends?
Baird Medical Investment Holdings Ltd does not currently pay dividends.
Where can I find BDMDW SEC filings?
Official SEC filings for Baird Medical Investment Holdings Ltd (CIK: 0001982444) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is BDMDW's EPS?
Baird Medical Investment Holdings Ltd has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is BDMDW a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Baird Medical Investment Holdings Ltd has a SELL rating with 84% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is BDMDW stock overvalued or undervalued?
Valuation metrics for BDMDW: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy BDMDW stock in 2026?
Our dual AI analysis gives Baird Medical Investment Holdings Ltd a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is BDMDW's free cash flow?
Baird Medical Investment Holdings Ltd's operating cash flow is N/A, with capital expenditures of N/A.
How does BDMDW compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio N/A (avg: 2).